LIfeMatrix develops novel,biomimetic cardiovascular implants

LifeMatrix Technologies AG

Incorporated

18.12.2018

Headquarters

Zurich

Support

LifeMatrix focuses on development novel, biomimetic implants in the cardiovascular space. These implants are made to mimic natural vessels and heart valves and are gradually replaced by native tissue after implantation. LifeMatrix is a R&D based organization which will be responsible for the development and registration of the novel products. Following registration of the products, it is planned that LifeMatrix will partner with larger organisations in this therapeutic space, who will sell the product on the market. As the key markets are initially the EU and the US, LifeMatrix plans to expand into both of these territories following the Series A financing round. In particular, LifeMatrix plans to open activities in the Boston area in order to further its development.